188 related articles for article (PubMed ID: 31600525)
1. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
[TBL] [Abstract][Full Text] [Related]
2. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
[TBL] [Abstract][Full Text] [Related]
3. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
Takayanagui OM; Bonato PS; Dreossi SA; Lanchote VL
Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631
[TBL] [Abstract][Full Text] [Related]
6. Albendazole failure to control resistant nematodes in lambs: lack of effect of fasting-induced improvement on drug absorption.
Alvarez L; Entrocasso C; Lifschitz A; Manazza J; Ceballos L; Borda B; Lanusse C
J Parasitol; 2010 Dec; 96(6):1204-10. PubMed ID: 21158637
[TBL] [Abstract][Full Text] [Related]
7. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Sotelo J; Jung H
Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
[TBL] [Abstract][Full Text] [Related]
10. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
[TBL] [Abstract][Full Text] [Related]
12. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Shinde RL; Bharkad GP; Devarajan PV
Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
[TBL] [Abstract][Full Text] [Related]
13. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Singh SK; Prasad KN; Singh AK; Gupta KK; Singh A; Tripathi M; Gupta RK
Exp Parasitol; 2017 Nov; 182():1-8. PubMed ID: 28821422
[TBL] [Abstract][Full Text] [Related]
15. Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
da Silva Santana RC; Prudente TP; de Sousa Guerra CH; de Lima NF; de Souza Lino Junior R; Vinaud MC
Exp Parasitol; 2023 Aug; 251():108568. PubMed ID: 37327965
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
García JJ; Bolás F; Torrado JJ
Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162
[TBL] [Abstract][Full Text] [Related]
17. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
[TBL] [Abstract][Full Text] [Related]
18. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of albendazole in children with neurocysticercosis.
Jung H; Sánchez M; González-Astiazarán A; Martínez JM; Suástegui R; González-Esquivel DF
Am J Ther; 1997 Jan; 4(1):23-6. PubMed ID: 10423586
[TBL] [Abstract][Full Text] [Related]
20. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
Gokbulut C; Akar F; McKellar QA
Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]